Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Burkitt Lymphoma
Pittsburgh, Pennsylvania
Burkitt Lymphoma Clinical Trials in Pittsburgh, Pennsylvania
1 recruiting
Pittsburgh, Pennsylvania
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Burkitt Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Double-Expressor Lymphoma
National Cancer Institute (NCI)
50 enrolled
4 locations
NCT07069699
Feedback